{
    "paper_id": "bd05cabd617f2868ee66e8686ca32db19e49c1fa",
    "metadata": {
        "title": "Supporting Information Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4- amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses",
        "authors": [
            {
                "first": "Dustin",
                "middle": [],
                "last": "Siegel",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Hon",
                "middle": [
                    "C"
                ],
                "last": "Hui",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Edward",
                "middle": [],
                "last": "Doerffler",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Michael",
                "middle": [
                    "O"
                ],
                "last": "Clarke",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Kwon",
                "middle": [],
                "last": "Chun",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Lijun",
                "middle": [],
                "last": "Zhang",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Sean",
                "middle": [],
                "last": "Neville",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Ernest",
                "middle": [],
                "last": "Carra",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Willard",
                "middle": [],
                "last": "Lew",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Bruce",
                "middle": [],
                "last": "Ross",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Queenie",
                "middle": [],
                "last": "Wang",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Lydia",
                "middle": [],
                "last": "Wolfe",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Robert",
                "middle": [],
                "last": "Jordan",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Veronica",
                "middle": [],
                "last": "Soloveva",
                "suffix": "",
                "affiliation": {
                    "laboratory": "United States Army Medical Research Institute of Infectious Diseases (USAMRIID)",
                    "institution": "",
                    "location": {
                        "settlement": "Frederick",
                        "region": "Maryland",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "John",
                "middle": [],
                "last": "Knox",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Jason",
                "middle": [],
                "last": "Perry",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Michel",
                "middle": [],
                "last": "Perron",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Kirsten",
                "middle": [
                    "M"
                ],
                "last": "Stray",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Ona",
                "middle": [],
                "last": "Barauskas",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Joy",
                "middle": [
                    "Y"
                ],
                "last": "Feng",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Yili",
                "middle": [],
                "last": "Xu",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Gary",
                "middle": [],
                "last": "Lee",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Arnold",
                "middle": [
                    "L"
                ],
                "last": "Rheingold",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "UC San Diego",
                    "location": {
                        "settlement": "San Diego",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Adrian",
                "middle": [
                    "S"
                ],
                "last": "Ray",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Roy",
                "middle": [],
                "last": "Bannister",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Robert",
                "middle": [],
                "last": "Strickley",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Swami",
                "middle": [],
                "last": "Swaminathan",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "William",
                "middle": [
                    "A"
                ],
                "last": "Lee",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Sina",
                "middle": [],
                "last": "Bavari",
                "suffix": "",
                "affiliation": {
                    "laboratory": "United States Army Medical Research Institute of Infectious Diseases (USAMRIID)",
                    "institution": "",
                    "location": {
                        "settlement": "Frederick",
                        "region": "Maryland",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Tomas",
                "middle": [],
                "last": "Cihlar",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Michael",
                "middle": [
                    "K"
                ],
                "last": "Lo",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Travis",
                "middle": [
                    "K"
                ],
                "last": "Warren",
                "suffix": "",
                "affiliation": {
                    "laboratory": "United States Army Medical Research Institute of Infectious Diseases (USAMRIID)",
                    "institution": "",
                    "location": {
                        "settlement": "Frederick",
                        "region": "Maryland",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Richard",
                "middle": [
                    "L"
                ],
                "last": "Mackman",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Gilead Sciences, Inc",
                    "location": {
                        "settlement": "Foster City",
                        "region": "California",
                        "country": "USA"
                    }
                },
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "compounds. Each plate included 16 wells of infected untreated cells and 16 wells of uninfected cells that served as 0% and 100% virus inhibition control, respectively. Following the infection, test plates were incubated for 48 h in a tissue culture incubator. Infection was terminated by fixing cells in formalin solution and virus replication was measured by quantifying the level of Ebola glycoprotein expressed in cells after immunostaining and high content imaging of the cells using the Perkin Elmer confocal microplate imager Opera. The percentage inhibition of virus infection was calculated for each tested concentration relative to the 0% and 100% inhibition controls and the EC 50 value for each compound was determined by 2-parametric non-linear regression as the effective concentration of compound that inhibited virus replication by 50%.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "S4"
        },
        {
            "text": "The antiviral activity was measured against EBOV (Kikwit) conducted in BSL-4 USAMRIID.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "EBOV Human Macrophage Antiviral Assay"
        },
        {
            "text": "Macrophage cultures were isolated from fresh human PBMCs and differentiated in the presence of 5 ng/ml GM-CSF and 50uM B-mercaptoethanol. The media was changed every 2 days and cells that adhered to the tissue culture plate after 7 days were removed with 0.5M EDTA in 1x PBS, concentrated by centrifugation at 200 x g for 10 min and plated in 384 well assay plates at 40,000 cells / well. The antiviral activity of each compound was measured in triplicate. Eight concentrations of each compound were added directly to the cell cultures using the HP300 digital dispenser in 3-fold serial dilution increments 2 h prior to infection. The plates were transferred to BSL-4 containment and the appropriate dilution of virus stock, previously determined by titration, was added to test plates containing cells and serially diluted compounds. Cells were incubated with virus only for 1 h and then virus was washed away and replaced with fresh media containing corresponding dilutions of each compound. Each plate included three wells of infected untreated cells and three wells of uninfected cells that served as 0% and 100% virus inhibition control, respectively. Following the infection, test plates were incubated for 48 h in a tissue culture incubator. Infection was stopped by fixing cells in formalin solution and virus replication was measured as described previously in Ebola HeLa antiviral assay.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "EBOV Human Macrophage Antiviral Assay"
        },
        {
            "text": "Compounds were 3-fold serially diluted in source plates from which 100 nL of diluted compound was transferred to a 384-well cell culture plate using an Echo acoustic transfer apparatus. HEp-2 S5 cells at a density of 5 \u00d7 10 5 cells/mL were then infected by adding RSV A2 at a titer of 1 \u00d7 10 4.5 tissue culture infectious doses (TCID 50 )/mL. Immediately following virus addition, 20 \u00b5L of the virus/cell mixture was added to the 384-well cell culture plates using a \u00b5Flow liquid dispenser and cultured for 4 days at 37 \u00b0C. After incubation, the cells were allowed to equilibrate to 25 \u00b0C for 30 min. The RSV-induced cytopathic effect was determined by adding 20 \u00b5L of CellTiter-Glo TM Viability Reagent. After a 10-min incubation at 25 \u00b0C, cell viability was determined by measuring luminescence using an Envision plate reader.",
            "cite_spans": [
                {
                    "start": 292,
                    "end": 295,
                    "text": "4.5",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "RSV A2 HEp-2 Antiviral Assay"
        },
        {
            "text": "For EC 50 and CC 50 determinations, compounds were serially diluted in ten steps of 1:3 dilutions in 384-well plates. All serial dilutions were performed in four replicates per compound within the same 384-well plate. An HCV protease inhibitor ITMN-191 at 100 \u00b5M was added as a control of 100% inhibition of HCV replication while puromycin at 10 mM was included as a control of 100% cytotoxicity. To each well of a black polystyrene 384-well plate (Greiner Bioone, Monroe, NC), 90 \u00b5L of cell culture medium (without Geneticin) containing 2000 suspended HCV replicon cells was added with a Biotek \u00b5Flow workstation. For compound transfer into cell culture plates, 0.4 \u00b5L of compound solution from the compound serial dilution plate was transferred to the cell culture plate on a Biomek FX workstation. The DMSO concentration in the final assay wells was 0.44%. The plates were incubated for 3 days at 37 \u00b0C with 5% CO 2 and 85% humidity. The HCV replicon assay was a multiplex assay, able to assess both cytotoxicity and antireplicon activity from the same well. The CC 50 assay was performed first. The media in the 384-well cell culture plate was aspirated, and the wells were washed four times with 100 \u00b5L ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HCV 1b Replicon Huh-7 Antiviral and Cytotoxicity Assay"
        },
        {
            "text": "HEp-2 (1.5 \u00d7 10 3 cells/well) and MT-4 (2 \u00d7 10 3 cells/well) cells were plated in 384-well plates and incubated with the appropriate medium containing 3-fold serially diluted compound ranging from 15 nM to 100,000 nM. Cells were cultured for 4-5 days at 37 \u00b0C. Following the incubation, the cells were allowed to equilibrate to 25 \u00b0C, and cell viability was determined by adding Cell-Titer Glo viability reagent. The mixture was incubated for 10 min, and the luminescence signal was quantified using an Envision plate reader. Cell lines were not authenticated and were not tested for mycoplasma as part of routine use in cytotoxicity assays.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Cytotoxicity Assays"
        },
        {
            "text": "Compounds were incubated at 2 \u00b5M in human plasma samples for up to 4 h at 37 \u00b0C. At the desired time points, an aliquot from the incubation was quenched by adding 9 volumes of 100% acetonitrile supplemented with internal standard. Following the last collection, the samples were centrifuged at 3,000 \u00d7 g for 30 min and the supernatants were transferred to a new plate containing an equal volume of water for analysis by LC/MS/MS. The data (analyte-to-internal standard peak area ratio) were plotted on a semi-log scale and fitted using an exponential fit. The half-life (t 1/2 ) was determined assuming first-order kinetics.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Human Plasma Stability."
        },
        {
            "text": "Liquid chromatography was performed using an Agilent 1200-series quaternary pump system (Agilent Technologies, Santa Clara, CA) with a 2 \u00b5m 20 \u00d7 2.1 mm Mercury RP C18 (Phenomenex, Torrance, CA). A HPLC system was coupled to a Quattro Premier triplequadrupole mass spectrometer (Waters, Milford, MA). Mass spectrometry was performed in positive-ion mode and multiple reaction monitoring modes using a Quattro Premier (Waters, Milford, MA). The test compound was eluted with a mobile phase consisting of 0.2% formic acid and a linear gradient from 0 to 95% acetonitrile over 2 min. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "LC/MS/MS Instrumentation"
        },
        {
            "text": "All natural deoxynucleoside triphosphates (dNTPs) and nucleoside triphosphates (NTPs) were from GE Healthcare (Piscataway, NJ). The [\u03b1-33 P]dNTPs and [\u03b1-33 P]NTPs were purchased from PerkinElmer (Waltham, MA). All of the biochemical assays used radiolabeled dNTP or NTP to track DNA or RNA product formation. The products were analyzed using affinity filter-binding or electrophoresis systems and quantified using a Typhoon Trio imager and ImageQuant TL software (GE Healthcare). All concentrations refer to the final concentrations unless mentioned otherwise. Product formation in the presence of the inhibitors was expressed as a percentage of the product in water-treated controls (defined as 100%). The IC 50 was defined as the concentration at which there was a 50% decrease in product formation. The data were analyzed using GraphPad Prism 5.0. IC 50 values were calculated as an average of at least three independent experiments. RSV ribonucleoprotein (RNP) complexes were prepared according to a method modified from Mason et al. 5 The recombinant human mitochondrial RNA polymerase (POLRMT) was purchased from Enzymax. RNA polymerase II was purchased as part of the \"HeLaScribe \u00ae Nuclear Extract in vitro Transcription System\" kit from Promega. Recombinant human DNA polymerases \u03b1 and \u03b2 were gifts from Robert Kuchta at the University of Colorado and Zucai Suo at the Ohio State University, respectively. Recombinant human DNA polymerase \u03b3 (including both the large subunit and the small subunit) was cloned, overexpressed, and purified based on published methods. 6,7",
            "cite_spans": [
                {
                    "start": 1038,
                    "end": 1039,
                    "text": "5",
                    "ref_id": "BIBREF13"
                }
            ],
            "ref_spans": [],
            "section": "Biochemical Assays"
        },
        {
            "text": "Transcription reactions contained 25 \u00b5g of crude RSV RNP complexes in 30 \u00b5L of reaction buffer (50 mM TRIS-acetate [pH 8.0], 120 mM potassium acetate, 5% glycerol, 4.5 mM MgCl 2 , 3 mM DTT, 2 mM EGTA, 50 \u00b5g/mL BSA, 2.5 U RNasin, 20 \u00b5M ATP, 100 \u00b5M GTP, 100 \u00b5M UTP, 100 \u00b5M CTP, and 1.5 \u00b5Ci [\u03b1-32 P]ATP [3,000 Ci/mmol]). The radiolabeled nucleotide used in the transcription assay was selected to match the nucleotide analog being evaluated for inhibition of RSV RNP transcription. To determine whether nucleotide analogs inhibited RSV RNP transcription, compounds were added using a 6-step serial dilution in 5-fold increments.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "RSV A2 Polymerase Inhibition Assay"
        },
        {
            "text": "After a 90 min incubation at 30 \u00b0C, the RNP, reactions were stopped with 350 \u00b5L of Qiagen RLT lysis buffer, and the RNA was purified using a Qiagen RNeasy 96 kit. Purified RNA was denatured in RNA sample loading buffer at 65 \u00b0C for 10 min and run on a 1.2% agarose/MOPS gel containing 2M formaldehyde. The agarose gel was dried, exposed to a Storm phosphorimaging screen, and developed using a Storm phosphorimager. water, and 1\u00d7 ethyl alcohol (EtOH). The filter paper was air-dried and exposed to the phosphorimager screen, and the amount of synthesized RNA was quantified as described earlier.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "RSV A2 Polymerase Inhibition Assay"
        },
        {
            "text": "All reaction mixtures contained 50 mM Tris-HCl buffer (pH 8.0), 0.2 mg/ml BSA, 2 mM DTT, 0.05 mg/ml activated fish sperm DNA, 10 mM MgCl2, 1.3 \u00b5Ci [\u03b1-33 P]dTTP (3,000 Ci/mmol), and 2 \u00b5Meach of dATP, dGTP, and TTP. The optimal enzyme concentrations were chosen to be in the linear range of enzyme concentration ([E]) versus activity, and the reaction time was S9 selected to ensure that 10% of the substrate was consumed. All reactions were run at 37 \u00b0C. The amounts of enzyme used in each assay were 160 nM and 30 nM for polymerase \u03b1 and \u03b2, respectively. For polymerase \u03b3 holoenzyme, 1.2 nM large catalytic subunit and 3.6 nM small accessory subunit were used in the assay. The incubation times were 30 min, 10 min, and 60 min for polymerases \u03b1, \u03b2, and \u03b3, respectively. The reactions were started by adding a mixture of the abovementioned natural NTPs and MgCl 2 into a preincubated mixture containing enzyme and inhibitors. At the end of the incubation, 5 \u00b5L of the reaction mixture was removed and spotted on DE81 anion exchange paper (Whatman, United Kingdom), which was washed with 3\u00d7 Na 2 HPO 4 (125 mM [pH 9]), 1\u00d7 water, and 1\u00d7 EtOH. The filer paper was air-dried and exposed to the ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Inhibition of Human DNA and RNA Polymerases"
        },
        {
            "text": "The synthesis and characterization data for the following compounds have been previously described: 4 [8] [9] [10] [11] [12] [13] , 4a 11,14 , 7 9,16 , 8 8,11,12 , 9 8,11,12 , 10 17 , 11 18, 19 , 11a 18, 19 , 12 20,11 , 13 12,21,22 , 13a 12,21,22 , 13b 12,21,22 , 4tp 10 , 13tp 13 . The synthesis and characterization for the following intermediates have been previously described: 18a 11 , 22a 10,11 , 22g 23 , 22i (single Sp isomer) 21, 22 . The second generation synthesis and characterization of 4, 4b, 16, 17, 21 and 22b has been described previously. 10",
            "cite_spans": [
                {
                    "start": 102,
                    "end": 105,
                    "text": "[8]",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 106,
                    "end": 109,
                    "text": "[9]",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 110,
                    "end": 114,
                    "text": "[10]",
                    "ref_id": null
                },
                {
                    "start": 115,
                    "end": 119,
                    "text": "[11]",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 120,
                    "end": 124,
                    "text": "[12]",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 125,
                    "end": 129,
                    "text": "[13]",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 154,
                    "end": 173,
                    "text": "8,11,12 , 9 8,11,12",
                    "ref_id": null
                },
                {
                    "start": 187,
                    "end": 190,
                    "text": "18,",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 191,
                    "end": 193,
                    "text": "19",
                    "ref_id": null
                },
                {
                    "start": 200,
                    "end": 203,
                    "text": "18,",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 204,
                    "end": 206,
                    "text": "19",
                    "ref_id": null
                },
                {
                    "start": 278,
                    "end": 280,
                    "text": "13",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 407,
                    "end": 409,
                    "text": "23",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 435,
                    "end": 438,
                    "text": "21,",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 439,
                    "end": 441,
                    "text": "22",
                    "ref_id": "BIBREF33"
                }
            ],
            "ref_spans": [],
            "section": "Preparation of Small Molecule Compounds"
        },
        {
            "text": "To a solution of Compound 22a (1.08 g, 2.4 mmol) in anhydrous DMF (9 mL ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino) propanoate (4a)"
        },
        {
            "text": "To a solution of compound 9 (15 mg, 0.053 mmol) in anhydrous THF (3 mL) was added t- ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "2-Ethylbutyl ((((2R,3S,4R,5S)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-ethynyl-3,4dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate (9a)"
        },
        {
            "text": "Phenyl dichlorophosphate (0.97 mL, 6.50 mmol) and ethyl 2-amino-2-methylpropanoate hydrochloride (1.09 g, 6.50 mmol) were dissolved in CH 2 Cl 2 (50 mL). The reaction mixture was cooled to about 0 \u00b0C and Et 3 N (1.75 mL, 12.5 mmol) was slowly added. The reaction mixture was allowed to warm to rt. After 2 h, p-nitrophenol (0.860 g, 6.17 mmol) was added followed by ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Ethyl 2-methyl-2-(((4-nitrophenoxy)(phenoxy)phosphoryl)amino)propanoate (22f)."
        },
        {
            "text": "Phenyl dichlorophosphate (1.49 mL, 10 mmol) was dissolved in 10 mL of anhydrous dichloromethane and stirred under atmosphere nitrogen in an ice bath. Cyclobutyl-L-alinate hydrochloride (0.9 g, 5 mmol) was added in one portion. Triethylamine (765 \u00b5L, 5.5 mmol) was then added dropwise. The reaction mixture was stirred for about 1 h, and triethylamine (765 \u00b5L, 5.50 mmol) was added dropwise and the reaction was stirred for about 45 min. p-Nitrophenol (1.25 g, 9 mmol) was added in one portion and stirred for about 30 min. Triethylamine (765 \u00b5L, 5.5 mmol) was added and the reaction mixture was stirred for about 2 h. Additional pnitrophenol (1.25 g, 9 mmol) and triethylamine (765 \u00b5L, 5.50 mmol) were then added, and the reaction was stirred for another 2 h. The reaction mixture was concentrated under reduced pressure, and the resulting crude residue was diluted with ethyl acetate and washed twice with 5% aqueous citric acid solution, and once with saturated aqueous sodium chloride solution. The organic layer was then dried over anhydrous sodium sulfate and concentrated under reduced pressure. The crude residue was purified with silica gel column chromatography (eluent: 0-50% S17 ethyl acetate in hexanes) to afford compound 22h (1.48 g, 70% yield as a mixture of diastereomers). 1 ",
            "cite_spans": [
                {
                    "start": 1290,
                    "end": 1291,
                    "text": "1",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "(2S)-cyclobutyl 2-(((4-nitrophenoxy)(phenoxy)phosphoryl)amino)propanoate (22h)."
        },
        {
            "text": "To a suspension of L-alanine tert-butylester hydrochloride (475 mg, 2.62 mmol) in methylene chloride (10 mL) was added phenyl dichlorophosphate (0.39 mL, 2.62 mmol) rapidly at -78 \u00b0C. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "tert-Butyl ((4-nitrophenoxy)(phenoxy)phosphoryl)-L-alaninate (22j)."
        },
        {
            "text": "To a suspension of cyclopentyl L-alaninate hydrochloride (800 mg, 4.13 mmol) in dichloromethane (10 mL) was added phenyl dichlorophosphate (0.615 mL, 4.13 mmol) at 0 \u00b0C.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Cyclopentyl ((perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate (22k)."
        },
        {
            "text": "Triethylamine (1.15 mL, 8.26 mmol) was then added and the resulting mixture was allowed to warm to rt. After 1 h, pentafluorophenol (0.760 mg, 4.13 mmol) was added followed by triethylamine (0.576 mL, 4.13 mmol) and the reaction mixture was stirred at rt. After 3.5 h, the reaction mixture was diluted with dichloromethane (50 mL) and was washed with saturate aqueous sodium carbonate solution (50 mL) and brine (50 mL), dried over sodium sulfate, and concentrated under reduced pressure. The crude residue was purified by silica gel column chromatography (eluent: 0-100% ethyl acetate in hexanes) to afford the desired product (0.872 g, S19",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Cyclopentyl ((perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate (22k)."
        },
        {
            "text": "To a suspension of neopentyl L-alaninate hydrochloride (400 mg, 2.04 mmol) in dichloromethane (5 mL) was added phenyl dichlorophosphate (0.304 mL, 2.04 mmol) at 0 \u00b0C.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Neopentyl ((perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate (22m)."
        },
        {
            "text": "Triethylamine (0.576 mL, 4.13 mmol) was then added and the resulting mixture was allowed to warm to rt. After 1 h, pentafluorophenol (0.376 mg, 2.044 mmol) was added followed by triethylamine (0.285 mL, 2.04 mmol) and the reaction mixture was stirred at rt. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Neopentyl ((perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate (22m)."
        },
        {
            "text": "Phenyl dichlorophosphate (345 \u00b5L, 2.38 mmol) was dissolved in anhydrous dichloromethane (24 mL) and was cooled to 0 \u00b0C under nitrogen atmosphere. 2-ethylbutyl D-alaninate hydrochloride (500 mg, 2.38 mmol) was added in one portion and triethylamine (730 \u00b5L, 5.24 mmol) was then S20 added dropwise. After 2 h, triethylamine (365 \u00b5L, 2.62 mmol) was added dropwise and the resulting mixture was stirred for an additional 30 min. p-Nitrophenol (265 mg, 1.9 mmol) was added in one portion and the reaction mixture was stirred at rt. After 2 h, the reaction mixture was diluted with dichloromethane (16 mL) and washed with 5% aqueous sodium carbonate solution (2\u00d7). The organic layer dried over anhydrous sodium sulfate and concentrated under reduced pressure. The crude residue was purified with silica gel column chromatography (eluent: 0-15% ethyl acetate in hexanes) to afford compound 22n (662 mg, 62% yield as a mixture of diastereomers). 1 ",
            "cite_spans": [
                {
                    "start": 88,
                    "end": 95,
                    "text": "(24 mL)",
                    "ref_id": null
                },
                {
                    "start": 938,
                    "end": 939,
                    "text": "1",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "2-Ethylbutyl ((4-nitrophenoxy)(phenoxy)phosphoryl)-D-alaninate (22n)."
        },
        {
            "text": "The single crystal X-ray Diffraction of compound 22b has been described previously. 10 The absolute stereochemistry of compound 22b is unambiguous. The X-ray crystallographic coordinates and structure factor files for compound 22b have been deposited in the Cambridge Structural Database (accession number 1445315, http://www.ccdc.cam.ac.uk/).",
            "cite_spans": [
                {
                    "start": 84,
                    "end": 86,
                    "text": "10",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Single Crystal X-ray Diffraction Single Crystal X-ray Diffraction of Compound 22b"
        },
        {
            "text": "The single crystal X-ray diffraction studies were carried out on a Bruker APEX CCD diffractometer equipped with Cu K \u03b1 radiation (\u03bb = 1.54178). A 0.220 \u00d7 0.080 \u00d7 0.040 mm colorless needle of 4b grown from a dichloromethane solution was mounted on a Cryoloop with Paratone oil. Data were collected in a nitrogen gas stream at 100(2) K using \u03c6 and \u03d6 scans. The diffractometer was a Bruker D8 platform equipped with a Nonius FR-591 rotating anode generator and micro-focus optics. Crystal-to-detector distance was 60 mm and exposure time was 5 s/frame using a scan width of 0.5\u00b0. Data collection was 97.9% complete to 65.67\u00b0 in \u03b8. A total of 14875 reflections were collected covering the indices, -12 < h < 12, -8 < k < 8, -25 < l < 25. 5666 reflections were found to be symmetry independent, with a R int of 0.0864. Indexing S21 and unit cell refinement indicated a primitive, monoclinic lattice. The space group was found to be P2 1 . The data were integrated using the Bruker SAINT software program and scaled using the SADABS software program. Solution by direct methods (SHELXS) produced a complete phasing model consistent with the proposed structure. All nonhydrogen atoms were refined anisotropically by full-matrix least-squares (SHELXL-97). All hydrogen atoms were placed using a riding model. Their positions were constrained relative to their parent atom using the appropriate HFIX command in SHELXL-97. The overall quality of this structure is compromised by weak and broad diffraction that may have resulted from a partial desolvation of the crystals. The absolute stereochemistry is about 95% reliable. The X-ray crystallographic coordinates and structure factor files for compound 4b have been deposited in the Cambridge",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Single Crystal X-ray Diffraction of Compound 4b"
        },
        {
            "text": "Database (accession number will be submitted on acceptance, http://www.ccdc.cam.ac.uk/). Figure S4 . Thermal ellipsoid representation of compound 4b.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 89,
                    "end": 98,
                    "text": "Figure S4",
                    "ref_id": null
                }
            ],
            "section": "Structural"
        },
        {
            "text": "Table S1",
            "cite_spans": [],
            "ref_spans": [],
            "section": "S22"
        },
        {
            "text": ". Crystal data and structure refinement for compound 4b. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "S22"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "44%) as a 1:1 mixture of isomers at phosphorus. The isomers were separated by chiral preparatory SFC to afford 22k as the second eluting isomer",
            "authors": [],
            "year": null,
            "venue": "Analytical SFC: Chiralpak IA",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "15 mL/15min at 1mL/min, 30% isopropyl alcohol in heptane",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Isomer Mixture: 1 H NMR (400 MHz, chloroform-d 1 ) \u03b4 7.39 -7.31 (m, 2H), 7.28 -7.17 (m, 3H), 5.23 -5.16 (m, 1H)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Hz, 2F), -153.78 (d, J = 21.0 Hz, 2F), -159.91 (td, J = 21",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Mhz ; D",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "20",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Second Eluting Isomer 22k: 1 H NMR (400 MHz, chloroform-d 1 ) \u03b4 7.39 -7.31 (m, 2H), 7.28 -7.17 (m, 3H), 5.23 -5.16 (m, 1H)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "-nitrophenoxy)(phenoxy)phosphoryl)-L-alaninate (22l)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "3-pentyl ester hydrochloride (1.00 g, 5.11 mmol) 24 was suspended in methylene chloride (15 mL) at -78 \u00b0C, and phenyl dichlorophosphate (0.76 mL, 5.11 mmol) was added",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "L-Alanine",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "42 mL, 10.2 mmol) was then added slowly over a 30 min period. 4-nitrophenol (711 mg, 5.11 mmol) was then added in one portion and triethylamine (0.71 mL, 5.11 mmol) References",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Triethylamine",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line",
            "authors": [
                {
                    "first": "V",
                    "middle": [],
                    "last": "Lohmann",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "K\u00f6rner",
                    "suffix": ""
                },
                {
                    "first": "J. -O",
                    "middle": [],
                    "last": "Koch",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Herian",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Theilmann",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Bartenschlager",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Science",
            "volume": "285",
            "issn": "",
            "pages": "110--113",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "IV Selection of Clinically Relevant Protease Inhibitor-Resistant Viruses Using the Genotype 2a Hepatitis C Virus Infection System",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Cheng",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Corsa",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Pokrovskii",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Paulson",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Bahador",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zhong",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Delaney",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Antimicrob. Agents Chemother",
            "volume": "55",
            "issn": "",
            "pages": "2197--2205",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "High-Throughput, Luciferase-Based Reverse Genetics Systems for Identifying Inhibitors of Marburg and Ebola Viruses",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "S"
                    ],
                    "last": "Uebelhoer",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "G"
                    ],
                    "last": "Albarino",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "K"
                    ],
                    "last": "Mcmullan",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "K"
                    ],
                    "last": "Chakrabarti",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "P"
                    ],
                    "last": "Vincent",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "T"
                    ],
                    "last": "Nichol",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "S"
                    ],
                    "last": "Towner",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Antiviral Res",
            "volume": "106",
            "issn": "",
            "pages": "86--94",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Generation of eGFP Expressing Recombinant Zaire Ebolavirus for Analysis of Early Pathogenesis Events and High-Throughput Antiviral Drug Screening",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "S"
                    ],
                    "last": "Towner",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Paragas",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "E"
                    ],
                    "last": "Dover",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Gupta",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "S"
                    ],
                    "last": "Goldsmith",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "W"
                    ],
                    "last": "Huggins",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "T"
                    ],
                    "last": "Nichol",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Virology",
            "volume": "332",
            "issn": "",
            "pages": "20--27",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Polyadenylation-dependent screening assay for respiratory syncytial virus RNA transcriptase activity and identification of an inhibitor",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "W"
                    ],
                    "last": "Mason",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Lawetz",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Gaudette",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "D\u00f4",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Scouten",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Lagac\u00e9",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Simoneau",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Liuzzi",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Nucleic Acids Res",
            "volume": "32",
            "issn": "",
            "pages": "4758--4767",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Human Mitrochondrial DNA Polymerase Holoenzyme: Reconstitution and Characterization",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "Johnson",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Tsai",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "W"
                    ],
                    "last": "Graves",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "A"
                    ],
                    "last": "Johnson",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Biochemistry",
            "volume": "39",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Expression, Purification, and Initial Kinetic Characterization of the Large Subunit of the Human Mitochondrial DNA Polymerase",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "W"
                    ],
                    "last": "Graves",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "Johnson",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "A"
                    ],
                    "last": "Johnson",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Biochemistry",
            "volume": "37",
            "issn": "",
            "pages": "6050--6058",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Synthesis and Antiviral Activity of a Series of 1\u2032-Substituted 4-aza-7,9-dideazaadenosine C-nucleosides",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Cho",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [
                        "L"
                    ],
                    "last": "Suanders",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Butler",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "E"
                    ],
                    "last": "Vela",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "Y"
                    ],
                    "last": "Feng",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Ray",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "U"
                    ],
                    "last": "Kim",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Bioorg. Med. Chem. Lett",
            "volume": "22",
            "issn": "",
            "pages": "2705--2707",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Practical Synthesis of 1\u2032-Substituted Tubercidin C-Nucleoside Analogs",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "E"
                    ],
                    "last": "Metobo",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [
                        "L"
                    ],
                    "last": "Saunders",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Butler",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Aktoudianakis",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Cho",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "U"
                    ],
                    "last": "Kim",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Tetrahedron Lett",
            "volume": "53",
            "issn": "",
            "pages": "484--486",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Therapeutic Efficacy of the Small Molecule GS-5734 Against Ebola Virus in Rhesus Monkeys",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "S"
                    ],
                    "last": "Fearns",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Swaminathan",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Mayers",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "L"
                    ],
                    "last": "Spiropoulou",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "F"
                    ],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "A"
                    ],
                    "last": "Nichol",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "T"
                    ],
                    "last": "Cihlar",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Bavari",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Nature",
            "volume": "531",
            "issn": "",
            "pages": "381--385",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Methods and Compounds for Treating Paramyxoviridae Virus Infections",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "L"
                    ],
                    "last": "Mackman",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "P"
                    ],
                    "last": "Parrish",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Ray",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "A"
                    ],
                    "last": "Theodore",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "1\u2032-Substituted Carbanucleoside Analogues for Antiviral treatment",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Butler",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Cho",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "U"
                    ],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [
                        "L"
                    ],
                    "last": "Saunders",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Processes and Intermediates for the Preparation of 1\u2032-substituted Carba-nucleoside Analogues",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Butler",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Cho",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "R"
                    ],
                    "last": "Graetz",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "U"
                    ],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "E"
                    ],
                    "last": "Metobo",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [
                        "L"
                    ],
                    "last": "Saunders",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "W"
                    ],
                    "last": "Waltman",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Methods for the Preparation of Ribosides",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Ross",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Rueden",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Scott",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "W"
                    ],
                    "last": "Siegel",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "A C"
                    ],
                    "last": "Stevens",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Tadeus",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Vieira",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "W"
                    ],
                    "last": "Waltman",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [
                        "X"
                    ],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "C"
                    ],
                    "last": "Whitcomb",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Wolfe",
                    "suffix": ""
                },
                {
                    "first": "C.-Y",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Methods for Treating Filoviridae Virus Infections",
            "authors": [
                {
                    "first": "B",
                    "middle": [
                        "K"
                    ],
                    "last": "Chun",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "O H"
                    ],
                    "last": "Clarke",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Doerffler",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "C"
                    ],
                    "last": "Hui",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Jordan",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "L"
                    ],
                    "last": "Mackman",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "P"
                    ],
                    "last": "Parrish",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Ray",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Siegel",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Triazines Useful for Treating Respiratory Syncitial Virus Infections",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "O H"
                    ],
                    "last": "Clarke",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Doerffler",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "L"
                    ],
                    "last": "Mackman",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Siegel",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "Cyanoribofuranoside Compound and Its Preparing Method",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zhen",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Guorong",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Yuyuan",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Chinese Patent",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Synthesis of 1\u2032-C-Cyano Pyrimidine Nucleosides and Characterization as HCV Polymerase Inhibitors",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "A"
                    ],
                    "last": "Kirschberg",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Mish",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "H"
                    ],
                    "last": "Squires",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Zonte",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Aktoudianakis",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Metobo",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Butler",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Ju",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Cho",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Ray",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "U"
                    ],
                    "last": "Kim",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Nucleosides, Nucleotides and Nucleic Acids",
            "volume": "34",
            "issn": "S26",
            "pages": "763--785",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "1\u2032-Substituted Pyrimidine N-Nucleoside Analogues for Antiviral Treatment",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Cho",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "U"
                    ],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "A"
                    ],
                    "last": "Kirschberg",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "R"
                    ],
                    "last": "Mish",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Squires",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "2\u2032-Fluoro Substituted Carba-Nucleoside Analogs for Antiviral Treatment",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "O H"
                    ],
                    "last": "Clarke",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "U"
                    ],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Lew",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "Discovery of the First C-nucleoside HCV Polymerase Inhibitor (GS-6620) with Demonstrated Antiviral Response in HCV Infected Patients",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Cho",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Butler",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Metobo",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Aktoudianakis",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Lew",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Ye",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Clarke",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Doerffler",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Byun",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Babusis",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Carey",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Berman",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Sauer",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zhong",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Rossi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Fenaux",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "G"
                    ],
                    "last": "Mchutchison",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Perry",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Feng",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Ray",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "U"
                    ],
                    "last": "Kim",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "J. Med. Chem",
            "volume": "57",
            "issn": "",
            "pages": "1812--1825",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Methods for the Preparation of Diastereomerically Pure Phosphoramidate Prodrugs",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Cho",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "A"
                    ],
                    "last": "Wolckenhauer",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "U.S. Patent",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "2\u2032-Fluoro Substituted Carba-Nucleoside Analogues for Antiviral Treatment",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Cho",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "U"
                    ],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "E"
                    ],
                    "last": "Metobo",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Ray",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "2\u2032-Ethynyl Nucleoside Derivatives for Treatment of Viral Infections",
            "authors": [
                {
                    "first": "S.-K",
                    "middle": [],
                    "last": "Anandan",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "S"
                    ],
                    "last": "Aulakh",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Fenaux",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Mao",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Saunders",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [
                        "K"
                    ],
                    "last": "Sweeney",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Fumiaki",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zhong",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "/water. The sample plate was shaken for 30 min, and 10 \u00b5L of the resulting solution was analyzed by HPLC/UV. The instrumentation used was an Alliance 2795 HPLC coupled with a photodiode array detector 2996 (Waters, Milford, MA) using a Waters XTerra 3.5 \u00b5m 4.6 mm \u00d7 50 mm C18 column. The mobile phase consisted of solvent A (20 mM ammonium acetate aqueous solution) and solvent B (100% acetonitrile). Elution was performed using a linear gradient of solvent B from 0% to 100% in 8 min. The log D value was calculated using the retention time of test compound compared to the reference compounds. The range of log D values for reference compounds is approximately between 0.3 and 5.7.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "A reaction mixture containing 50 mM Tris-HCl (pH 7.5), 10 mM KCl, 1 mM dithiothreitol (DTT), 0.1 mg/ml bovine serum albumin (BSA), 0.2 U/\u00b5L RNasin Plus RNase inhibitor (Promega),4 ng/\u00b5L sshRNA, 5 mM MgCl2, and 70 to 150 nM wild-type HCV NS5B was preincubated with NTP analog for 5 min at room temperature. The reaction was initiated by adding a mixture containing 2.5 \u00b5M ATP, 2.5 \u00b5M CTP, 2.5 \u00b5M UTP, 1.25 \u00b5M GTP, and 0.06 \u00b5Ci/\u00b5L of [\u03b1-33 P]GTP (3,000 mCi/mol). The reactions were allowed to proceed for 90 min at 30 \u00b0C. After 90 min, 10 \u00b5L of the reaction mixture was spotted on DE81 anion exchange paper (Whatman, United Kingdom), which was then washed with 3\u00d7 Na 2 HPO 4 (125 mM [pH 9]), 1\u00d7",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "phosphorimager screen prior to quantification and analysis. Human RNA polymerase II reactions were conducted by preincubating 7.5 \u00b5L 1\u00d7 transcription buffer (20 mM HEPES [pH 7.2 to 7.5], 100 mM KCl, 0.2 mM EDTA, 0.5 mM DTT, 20% glycerol), 3 mM MgCl 2 , 100 ng cytomegalovirus (CMV)-positive control DNA (Promega), a mixture of natural NTPs, and various concentrations of the inhibitors at 30 \u00b0C for 5 min. The mixture of four natural NTPs contained 5 \u00b5Ci of the competing NTP, with the concentration set at the K m , and 400 \u00b5M the three noncompeting NTPs. The reaction was started by adding 3.5 \u00b5L of HeLa Extract to a final 25 \u00b5L reaction mixture. After 1 h incubation at 30 \u00b0C, the polymerase reaction was stopped by adding 10.6 \u00b5L of proteinase K mixture, which contained final concentrations of 2.5 \u00b5g/\u00b5L proteinase K (New England BioLabs), 5% SDS, and 25 mM EDTA. After incubation at 37 \u00b0C for 3 to 12 h, 10 \u00b5L of the reaction mixture was mixed with 10 \u00b5L of the loading dye (98% formamide, 0.1% xylene cyanol, and 0.1% bromophenol blue), heated at 75 \u00b0C for 5 min, and loaded onto a 6% polyacrylamide gel (8 M urea). The gel was dried for 45 min at 70 \u00b0C and the full-length product (363 nt runoff RNA) was quantified. The inhibition of mitochondrial RNA polymerase (POLRMT) was evaluated using 20 nM POLRMT preincubated with 20 nM template plasmid (pUC18-LSP) containing POLRMT light-strand promoter region and mitochondrial transcription factor A (mtTFA) (100 nM) and mt-TFB2 (20 nM) in buffer containing 10 mM HEPES (pH 7.5), 20 mMNaCl, 10 mM DTT, 0.1 mg/ml BSA, and 10 mM MgCl 2 . The reactions were heated to 32 \u00b0C and initiated by adding 2.5 \u00b5M each of the four natural NTPs and 1.5 \u00b5Ci of [ 33 P]GTP. After incubation for 30 min at 32 \u00b0C, the reactions were spotted on DE81 paper before being processed for quantification. Single Nucleotide Incorporation by Mitochondrial RNA Polymerase S10 A mixture of MTCN buffer (50 mM MES, 25 mM Tris-HCl, 25 mM CAPS, 30 \u00b0C for 1 min. The reaction was started by addition of 500 \u00b5M (final) natural NTP or NTP analogs. At selected time points, the reaction mixture was removed and quenched with gel loading buffer containing 100 mM EDTA, 80% formamide, and bromophenol blue, and heated at 65 \u00b0C for 5 min. The samples were run on a 20% polyacrylamide gel (8 M urea), and the product formation was quantified using Typhoon Trio Imager and Image Quant TL Software (GE Healthcare, Piscataway, NJ). The rate of single nucleotide incorporation by mt RNA pol was calculated by fitting the product formation using the single exponential equation: [R13] = A(1 \u2212 e \u2212kt ), where [R13] represents the amount (in nM) of the elongated product formed, t represents the reaction time, k represents the observed rate, and A represents the amplitude of the exponential. Single Nucleotide Incorporation by Mitochondrial DNA Polymerase \u03b3 An annealed 32 P labeled primer-template D19/D36, 1.2 nM DNA Pol \u03b3 large subunit, and 3.4 nM Pol \u03b3 accessory subunit are preincubated on ice for 5 min and added to reaction mixture containing 50 mM Tris-Cl (pH 8.0), 2 mM DTT, 0.2 mg/mL BSA, 200 nM D19/D36 mer and 10 mM MgCl 2 . Reactions are heated to 37 \u00b0C and initiated by addition of 50 \u00b5M (final) natural dNTP or analog, plus 50 \u00b5M of a natural dNTP that allows the primer to regenerate after 3\u2032excision by the exonuclease activity of the enzyme. At 0, 5, 10, 30, 60, and 90 min, 10 \u00b5L of the reaction mixture is removed and quenched with 10 \u00b5L of a gel loading buffer containing 100 mM EDTA, 80% formamide and bromophenol blue, and heated at 65 \u00baC for 5 min. The samplesare run on a 20% polyacrylamide gel (8 M urea) and the gel is exposed to a phosphorimager screen. The substrate and the incorporation products, D19 and D20-28, are quantified using a Typhoon Trio Imager and Image Quant TL Software. The rate of nucleotide incorporation is calculated in Prism by fitting the product formation using the single exponential equation: [D20] = A(1 -e -kt ), where [D20] represents the amount (in nM) of the elongated product formed, t represents the reaction time, k represents the observed rate, and A represents the amplitude of the exponential. Analog incorporation rates are calculated as % incorporation relative to natural dNTP.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "York, NY, 2015, default settings with subsequent rigid body minimization and side chain optimization. Loop insertions not in 1RTD of greater than 10 amino acids were not built. Resulting models of 4tp and 13tp docked in the EBOV active site are available among the Supplementary Material as EBOV_4-TP_model.pdb and EBOV_13-TP_model.pdb. Homology of RSV A2 (Pubmed AOD41217), Marburg virus (Pubmed AAR85466) and Sudan virus (Pubmed AAA79970) as mapped to the EBOV polymerase active site. Residues in red are conserved and residues in yellow are similar. Overall, the active site is highly conserved among the filovirus family.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF4": {
            "text": "Homolgy model of RSV A2 polymerase active site onto EBOV with compound 4tp (green stick).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF5": {
            "text": "Homolgy model of Marburg virus polymerase active site onto EBOV with compound 4tp (green stick).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF6": {
            "text": "Homolgy model of Sudan virus polymerase active site onto EBOV with compound 4tp (green stick).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF8": {
            "text": ") at rt was added 4 (350 mg, 1.2 mmol) in one portion. A solution of t-butylmagnesium chloride in THF (1M, 1.8 mL, 1.8 mmol) was then added to the reaction dropwise over about 10 min. The reaction was stirred for about 2 h, at which point the reaction mixture was diluted with ethyl acetate (50 mL) and washed with saturated aqueous sodium bicarbonate solution (3 x 15 mL) followed by saturated aqueous sodium chloride solution (15 mL). The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The resulting oil was purified with silica gel column chromatography (eluent: 0-10% methanol in dichloromethane) to 4a (311 mg, 43%, 1 : 0.4 diastereomeric mixture at phosphorus). 1 H NMR (400 MHz, methanol-d 4 ) \u03b4 7.85 (m, 1H), 7.34 -7.23 (m, 2H), 7.21 -7.09 (m, 3H), 6.94 -6.84 (m, 2H), 4.78 (d, J = 5.4 Hz, 1H), 4.46 -4.33 (m, 2H), 4.33 -4.24 (m, 1H), 4.18 (m, 1H), 4.05 -3.80 (m, 3H), 1.52 -1.39 (m, 1H), 1.38 -1.20 (m, 7H), 0.85 (m, 6H). 31 P NMR (162 MHz, methanol-d 4 ) \u03b4 3.71, 3.65. MS m/z 603.1 [M+1].",
            "latex": null,
            "type": "figure"
        },
        "FIGREF9": {
            "text": "(1M in THF, 79 \u00b5L, 0.079 mmol) at rt under a nitrogen atmosphere. After 20 min, a solution of 19 (47 mg, 0.106 mmol) in anhydrous THF (3 mL) was added and the resulting S15 mixture was warmed to 50 \u00b0C. After 12 h, the reaction mixture was concentrated under reduced pressure and the crude residue was purified by reverse phase preparatory HPLC to afford compound 9a (6.6 mg, 21%, ~1:1 diastereomeric mixture at phosphorus). HRMS (m/z): [M] + calcd for C 28 H 36 N 5 O 8 P, 602.2307; found, 602.2380. HPLC: t R = 5.572 min, 5.622 min.(2S)-ethyl 2-(((4-nitrophenoxy)(phenoxy)phosphoryl)amino)-3-phenylpropanoate (22d). (S)-ethyl 2-amino-3-phenylpropanoate hydrochloride (1.01 g, 4.41 mmol) was dissolved in dichloromethane (50 mL). This solution was cooled to about 0 \u00b0C and PhOP(O)Cl 2 (0.656 mL, 4.41 mmol) was added, followed by the slow addition of Et 3 N (1.62 mL, 11.5 mmol) over 5 min. The cold bath was removed and the reaction was allowed to warm to rt and stir over a period of 80 min. p-NO 2 PhOH (0.583 g, 4.19 mmol) was added, followed by more Et 3 N (0.3 mL, 2.1 mmol). The reaction progress was monitored by LC/MS. Upon completion of the reaction, it was diluted with Et 2 O, and the resulting solids were removed by filtration. The filtrate was concentrated the crude residue was purified by silica gel column chromatography (eluent: 0-55% ethyl acetate in hexanes) to afford compound 22d (1.25 g, 60%, as a mixture of diastereomers). 1 H NMR (400 MHz, methanol-d 4 ) \u03b4 8.17 (m, 2H), 7.33 (m, 2H), 7.09-7.25 (m, 10H), 4.17 (m, 1H), 4.07 (m, 2H), 3.08 (m, 1H), 2.84 (m, 1H), 1.14 (m, 3H). 31 P NMR (162 MHz, DMSO-d 6 ) \u03b4 -1.479 (s), -1.719 (s). MS m/z = 471.01 [M+1].(2S)-ethyl 3-methyl-2-(((4-nitrophenoxy)(phenoxy)phosphoryl)amino) butanoate (22e).(S)-Ethyl 2-amino-3-methylbutanoate (0.351 g, 1.93 mmol) was dissolved in CH 2 Cl 2 (17 mL).This solution was cooled in an ice bath and PhOP(O)Cl 2 (0.287 mL, 1.93 mmol) was added, followed by the slow addition of Et 3 N (1.62 mL, 11.4 mmol) over about 5 min. The cold bath was removed and the reaction was allowed to warm to rt and stir over a period of 1 h. p-NO 2 PhOH (0.255 g, 1.83 mmol) was added, and the reaction progress was monitored by LC/MS. Upon completion of the reaction, the mixture was diluted with Et 2 O, and the resulting solids were removed by filtration. The filtrate was concentrated and the crude residue was purified by silica gel column chromatography (eluent: 0-55% ethyl acetate in hexanes) to afford compound 22e (0.642 g, 79%, as a mixture of diastereomers). 1 H NMR (400 MHz, DMSO-d 6 ) \u03b4 8.30 (d,",
            "latex": null,
            "type": "figure"
        },
        "FIGREF10": {
            "text": "mmol). After about 2 h, the reaction was determined to be complete by LCMS. The reaction was diluted with Et 2 O and the precipitate was removed by filtration. The resulting filtrate was concentrated under reduced pressure and the crude residue was purified by silica gel chromatography (eluent: 0-50% ethyl acetate in hexanes) to afford compound 22f (1.79 g, 68%). 1 H NMR (400 MHz, DMSO-d 6 ) \u03b4 8.37 -8.21 (m, 2H), 7.55 -7.44 (m, 2H), 7.43 -7.33 (m, 2H), 7.30 -7.09 (m, 3H), 6.57 (d, J = 10.1 Hz, 1H), 3.99 (q, J = 7.1 Hz, 2H), 1.39 (s, 6H), 1.08 (t, J = 7.1 Hz, 3H). 31 P NMR (162 MHz, DMSO-d 6 ) \u03b4 -2.87. MS m/z = 408.97 [M+1].",
            "latex": null,
            "type": "figure"
        },
        "FIGREF11": {
            "text": ". MS m/z = 420.9 [M+1].",
            "latex": null,
            "type": "figure"
        },
        "FIGREF12": {
            "text": "A solution of triethylamine (0.72 mL, 5.24 mmol) in methylene chloride (1.5 mL) was then added over 60 min at -78 \u00b0C and the resulting mixture was stirred at room temperature for 3 h.The reaction mixture was cooled to 0 \u00b0C and 4-nitrophenol (364 mg, 2.62 mmol) was added in one portion. Then triethylamine (0.36 mL, 2.62 mmol) was added over 60 min and the reaction mixture was stirred at rt. After 3 h, the reaction mixture was diluted with ethyl acetate, washed with saturate aqueous sodium carbonate solution (3 \u00d7), dried over sodium sulfate, and concentrated under reduced pressure. The crude residue was purified by silica gel column chromatography (eluent: 0-35% ethyl acetate in hexanes) to afford 22j (2.3 g, 79%). 1 H NMR (400 MHz, chloroform-d 1 ) \u03b4 8.30 -8.18 (m, 2H), 7.46 -7.29 (m, 4H), 7.31 -7.14 (m, 3H), 4.01 (tt, J = 8.5, 6.5 Hz, 1H), 3.93 -3.70 (m, 1H), 1.43 (s, 9H), 1.37 (dd, J = 7.0, 2.0 Hz, 3H). 31 P NMR (162 MHz, chloroform-d 1 ) \u03b4 -2.85. MS m/z = 844 [2M+1].",
            "latex": null,
            "type": "figure"
        },
        "FIGREF13": {
            "text": "was diluted with dichloromethane (20 mL) and was washed with saturate aqueous sodium carbonate solution (20 mL) and brine (20 mL), dried over sodium sulfate, and concentrated under reduced pressure. The crude residue was purified by silica gel column chromatography (eluent: 0-100% ethyl acetate in hexanes) to afford the desired product (0.225 g, 23%) as a 1:1 mixture of isomers at phosphorus. The isomers were separated by chiral preparatory SFC to afford 22m as the second eluting isomer. (Analytical: Chiralpak IA, 150 x 4.6 mm, 5 micron, 15 mL/15min at 1mL/min, 30% isopropyl alcohol in heptane; First Eluting Isomer t R = 2.929 min, Second Eluting Isomer 22m t R = 3.512 min). 1:1 Isomer Mixture: 1 H NMR (400 MHz, chloroform-d 1 ) \u03b4 7.39 -7.31 (m, 2H), 7.27 -7.18 (m, 3H), 4.28 -4.15 (m, 1H), 4.08 -3.95 (m, 1H), 3.93 -3.74 (m, 2H), 1.52 -1.46 (m, 3H), 0.96 -0.92 (m, 9H). 31 P NMR (162 MHz, chloroform-d 1 ) \u03b4 -1.54 (br). 19 F NMR (376 MHz, chloroform-d 1 ) \u03b4 -153.70 (d, J = 20.3 Hz, 2F), -153.81 (d, J = 19.9 Hz, 2F), -159.80 (br t, J = 22.9 Hz, 1F), -159.98 (td, J = 21.6, 3.3 Hz), -162.44 --162.74 (m, 4F). MS m/z = 482.00 [M+1]. Second Eluting Isomer 22m: 1 H NMR (400 MHz, chloroform-d 1 ) \u03b4 7.39 -7.31 (m, 2H), 7.27 -7.18 (m, 3H), 4.28 -4.15 (m, 1H), 4.08 -3.95 (m, 1H), 3.88 (d, J = 10.5 Hz, 1H), 3.81 (d, J = 10.5 Hz, 1H), 1.49 (d, J = 7.1 Hz, 3H), 0.93 (s, 9H). 31 P NMR (162 MHz, chloroform-d 1 ) \u03b4 -1.58. 19 F NMR (376 MHz, chloroform-d 1 ) \u03b4 -153.84 (d, J = 20.9 Hz, 2F), -159.92 (td, J = 21.9, 3.6 Hz, 1F), -162.63 (app dd, J = 21.9, 17.8 Hz, 2F). MS m/z = 481.97 [M+1].",
            "latex": null,
            "type": "figure"
        },
        "FIGREF14": {
            "text": "48. MS m/z = 451 [M+1].",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "of PBS each, using a Biotek ELX405 plate washer. A volume of 50 \u00b5L of a solution containing 400 nM calcein AM (Anaspec, Fremont, CA) in 1 \u00d7 PBS was added to each well of the plate with a Biotek \u00b5Flow workstation. The plate was incubated for 30 min at room temperature before the fluorescence signal (excitation 490 nm, emission 520 nm) was measured with a Perkin-Elmer Envision plate reader. The EC 50 assay was performed in the same wells as the CC 50 assay. The calcein-PBS solution in the 384-well cell culture plate was aspirated with a Biotek ELX405 plate washer. A volume of 20 \u00b5L of Dual-Glo luciferase buffer (Promega, Madison, WI) was added to each well of the plate with a Biotek \u00b5Flow Workstation. The plate was incubated for 10 min at room temperature. A volume of 20 \u00b5L of a solution containing a S6 1:100 mixture of Dual-Glo Stop & Glo substrate (Promega, Madison, WI) and Dual-Glo Stop & Glo buffer (Promega, Madison, WI) was added to each well of the plate with a Biotek \u00b5Flow Workstation. The plate was then incubated at room temperature for 10 min before the luminescence signal was measured with a Perkin-Elmer Envision Plate Reader.",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}